Literature DB >> 17087966

The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice.

Daniel Eefting1, Abbey Schepers, Margreet R De Vries, Nuno M M Pires, Jos M Grimbergen, Tonny Lagerweij, Lex M Nagelkerken, Pascalle S Monraats, J Wouter Jukema, J Hajo van Bockel, Paul H A Quax.   

Abstract

OBJECTIVE: Inflammatory factors are thought to play a regulatory role in restenosis. Interleukin-10 (IL10) is an important anti-inflammatory cytokine with anti-atherogenic potentials. The aim of this study was to assess the effects of IL10 modulation on cuff-induced neointima formation in hypercholesterolemic APOE*3-Leiden mice.
METHODS: The involvement of IL10 in neointima formation was studied in a hypercholesterolemic mouse model of cuff-induced stenosis of the femoral artery by IL10 knocking-out or overexpression procedures. IL10(+/-) mice were crossbred with APOE*3-Leiden mice to generate hypercholesterolemic APOE*3-LeidenIL10(-/-) mice. To achieve IL10 overexpression in APOE*3-Leiden mice, a single intramuscular injection of a murine IL10 overexpression plasmid was performed followed by electroporation.
RESULTS: Knocking-out IL10, in hypercholesterolemic APOE*3-Leiden mice, resulted in a significant 1.9-fold increase of neointima surface as compared to APOE*3-LeidenIL10(+/+) littermates (p=0.02). Conversely, a marked 45% inhibition on cuff-induced neointima formation was obtained after IL10 overexpression (p=0.02). Electrodelivery of IL10 vector leads to detectable IL10 serum levels, with a sustained expression over the experimental period of 3 weeks. IL10 overexpression reduced plasma cholesterol levels in APOE*3-Leiden mice, whereas IL10 deficiency in these mice did not lead to altered cholesterol levels as compared to the IL10(+/+) group. Finally, IL10 overexpression stimulated endogenous IL10 mRNA expression in the spleen and reduced the transcriptional responses of several pro-inflammatory cytokines.
CONCLUSION: Here, we clearly demonstrate the role of IL10 in the development of neointima formation in hypercholesterolemic mice and the potential therapeutic effect of non-viral electrodelivery of IL10 cDNA to inhibit post-angioplasty restenosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17087966     DOI: 10.1016/j.atherosclerosis.2006.09.032

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  18 in total

1.  Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats.

Authors:  Hong-Bo Jin; Yong-Bin Yang; Ying-Li Song; Yong-chun Zhang; Yu-Rong Li
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

Review 2.  Restenosis after PCI. Part 1: pathophysiology and risk factors.

Authors:  J Wouter Jukema; Jeffrey J W Verschuren; Tarek A N Ahmed; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-09-13       Impact factor: 32.419

Review 3.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

4.  VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.

Authors:  Xiao-Feng Yang; Ying Yin; Hong Wang
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 5.  Intimal hyperplasia in murine models.

Authors:  David Y Hui
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

6.  Overexpression of NF-κB p65 in macrophages ameliorates atherosclerosis in apoE-knockout mice.

Authors:  Xin Ye; Xiaoting Jiang; Wei Guo; Katie Clark; Zhanguo Gao
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-08       Impact factor: 4.310

7.  Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study.

Authors:  Susan G Lakoski; Yongmei Liu; K Bridget Brosnihan; David M Herrington
Journal:  Atherosclerosis       Date:  2007-08-13       Impact factor: 5.162

Review 8.  T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword.

Authors:  Karin H Simons; Alwin de Jong; J Wouter Jukema; Margreet R de Vries; Ramon Arens; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

9.  Effect of Ligusticum wallichii aqueous extract on oxidative injury and immunity activity in myocardial ischemic reperfusion rats.

Authors:  Qiao Zengyong; Ma Jiangwei; Liu Huajin
Journal:  Int J Mol Sci       Date:  2011-03-18       Impact factor: 5.923

10.  TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.

Authors:  Jacco C Karper; Mark M Ewing; Margreet R de Vries; Saskia C A de Jager; Erna A B Peters; Hetty C de Boer; Anton-Jan van Zonneveld; Johan Kuiper; Eric G Huizinga; T Harma C Brondijk; J Wouter Jukema; Paul H A Quax
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.